These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 7578131

  • 1. Cooperativity and binding in the mechanism of cytosolic phospholipase A2.
    Burke JR, Witmer MR, Tredup J, Micanovic R, Gregor KR, Lahiri J, Tramposch KM, Villafranca JJ.
    Biochemistry; 1995 Nov 21; 34(46):15165-74. PubMed ID: 7578131
    [Abstract] [Full Text] [Related]

  • 2. The size and curvature of anionic covesicle substrate affects the catalytic action of cytosolic phospholipase A2.
    Burke JR, Witmer MR, Tredup JA.
    Arch Biochem Biophys; 1999 May 15; 365(2):239-47. PubMed ID: 10328818
    [Abstract] [Full Text] [Related]

  • 3. Presence of glycerol masks the effects of phosphorylation on the catalytic efficiency of cytosolic phospholipase A2.
    Burke JR, Guenther MG, Witmer MR, Tredup JA, Hail ME, Micanovic R, Villafranca JJ.
    Arch Biochem Biophys; 1997 May 01; 341(1):177-85. PubMed ID: 9143367
    [Abstract] [Full Text] [Related]

  • 4. Membrane penetration of cytosolic phospholipase A2 is necessary for its interfacial catalysis and arachidonate specificity.
    Lichtenbergova L, Yoon ET, Cho W.
    Biochemistry; 1998 Oct 06; 37(40):14128-36. PubMed ID: 9760249
    [Abstract] [Full Text] [Related]

  • 5. Interfacial catalysis by human 85 kDa cytosolic phospholipase A2 on anionic vesicles in the scooting mode.
    Bayburt T, Gelb MH.
    Biochemistry; 1997 Mar 18; 36(11):3216-31. PubMed ID: 9115999
    [Abstract] [Full Text] [Related]

  • 6. Cytosolic phospholipase A2 shows burst kinetics consistent with the slow, reversible formation of a dead-end complex.
    Guenther MG, Witmer MR, Burke JR.
    Arch Biochem Biophys; 2002 Feb 01; 398(1):101-8. PubMed ID: 11811954
    [Abstract] [Full Text] [Related]

  • 7. Synergism between mellitin and phospholipase A2 from bee venom: apparent activation by intervesicle exchange of phospholipids.
    Cajal Y, Jain MK.
    Biochemistry; 1997 Apr 01; 36(13):3882-93. PubMed ID: 9092818
    [Abstract] [Full Text] [Related]

  • 8. A beta-lactam inhibitor of cytosolic phospholipase A2 which acts in a competitive, reversible manner at the lipid/water interface.
    Burke JR, Gregor KR, Padmanabha R, Banville J, Witmer MR, Davern LB, Manly SP, Tramposch KM.
    J Enzyme Inhib; 1998 Jun 01; 13(3):195-206. PubMed ID: 9629537
    [Abstract] [Full Text] [Related]

  • 9. 15-Lipoxygenation of phospholipids may precede the sn-2 cleavage by phospholipases A2: reaction specificities of secretory and cytosolic phospholipases A2 towards native and 15-lipoxygenated arachidonoyl phospholipids.
    Chaitidis P, Schewe T, Sutherland M, Kühn H, Nigam S.
    FEBS Lett; 1998 Sep 04; 434(3):437-41. PubMed ID: 9742970
    [Abstract] [Full Text] [Related]

  • 10. Calcium-dependent and -independent interfacial binding and catalysis of cytosolic group IV phospholipase A2.
    Hixon MS, Ball A, Gelb MH.
    Biochemistry; 1998 Jun 09; 37(23):8516-26. PubMed ID: 9622504
    [Abstract] [Full Text] [Related]

  • 11. Multiple enzymatic activities of the human cytosolic 85-kDa phospholipase A2: hydrolytic reactions and acyl transfer to glycerol.
    Hanel AM, Gelb MH.
    Biochemistry; 1995 Jun 20; 34(24):7807-18. PubMed ID: 7794891
    [Abstract] [Full Text] [Related]

  • 12. A phospholipase A2 hydrolyzing arachidonoyl-phospholipids in mouse peritoneal macrophages.
    Wijkander J, Sundler R.
    FEBS Lett; 1989 Feb 13; 244(1):51-6. PubMed ID: 2494067
    [Abstract] [Full Text] [Related]

  • 13. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release.
    Huwiler A, Johansen B, Skarstad A, Pfeilschifter J.
    FASEB J; 2001 Jan 13; 15(1):7-9. PubMed ID: 11099485
    [Abstract] [Full Text] [Related]

  • 14. Use of an imperfect neutral diluent and outer vesicle layer scooting mode hydrolysis to analyze the interfacial kinetics, inhibition, and substrate preferences of bee venom phospholipase A2.
    Yu BZ, Ghomashchi F, Cajal Y, Annand RR, Berg OG, Gelb MH, Jain MK.
    Biochemistry; 1997 Apr 01; 36(13):3870-81. PubMed ID: 9092817
    [Abstract] [Full Text] [Related]

  • 15. Competitive, reversible inhibition of cytosolic phospholipase A2 at the lipid-water interface by choline derivatives that partially partition into the phospholipid bilayer.
    Burke JR, Witmer MR, Zusi FC, Gregor KR, Davern LB, Padmanabha R, Swann RT, Smith D, Tredup JA, Micanovic R, Manly SP, Villafranca JJ, Tramposch KM.
    J Biol Chem; 1999 Jul 02; 274(27):18864-71. PubMed ID: 10383382
    [Abstract] [Full Text] [Related]

  • 16. Phosphatidylethanol stimulates calcium-dependent cytosolic phospholipase A(2) activity of a macrophage cell line (RAW 264.7).
    Chang CY, Farrell KR, Baker RC.
    J Biomed Sci; 2000 Jul 02; 7(4):311-6. PubMed ID: 10895054
    [Abstract] [Full Text] [Related]

  • 17. Processive interfacial catalysis by mammalian 85-kilodalton phospholipase A2 enzymes on product-containing vesicles: application to the determination of substrate preferences.
    Hanel AM, Schüttel S, Gelb MH.
    Biochemistry; 1993 Jun 15; 32(23):5949-58. PubMed ID: 8507635
    [Abstract] [Full Text] [Related]

  • 18. Mammalian secreted and cytosolic phospholipase A2 show different specificities for phospholipid molecular species.
    Burdge GC, Creaney A, Postle AD, Wilton DC.
    Int J Biochem Cell Biol; 1995 Oct 15; 27(10):1027-32. PubMed ID: 7496992
    [Abstract] [Full Text] [Related]

  • 19. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7.
    Leslie CC, Voelker DR, Channon JY, Wall MM, Zelarney PT.
    Biochim Biophys Acta; 1988 Dec 16; 963(3):476-92. PubMed ID: 3143418
    [Abstract] [Full Text] [Related]

  • 20. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.
    Burke JR, Davern LB, Stanley PL, Gregor KR, Banville J, Remillard R, Russell JW, Brassil PJ, Witmer MR, Johnson G, Tredup JA, Tramposch KM.
    J Pharmacol Exp Ther; 2001 Jul 16; 298(1):376-85. PubMed ID: 11408565
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.